【レポートの概要(一部)】
1. Report Overview
1.1 The Global Pharma Wholesale and Distribution Industry and Market Review
1.2 The Global Pharma Wholesale and Distribution Industry Structure
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Who is This Study For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistics Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribute a Large Amount of Products to Generate High Profit
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generating Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clearer Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US
3. The World Pharmaceutical Wholesale and Distribution Market, 2014-2024
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2013, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution: World Market Forecast, 2014-2024
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2014-2024
3.3.1 Branded and Generic Drugs: Revenue Generation, 2013
3.3.2 Branded Drugs, Generic Drugs and Others: Revenue Forecasts, 2014-2024
3.3.3 Branded Drugs: Revenue Forecast, 2014-2024
3.3.4 Generic Drugs: Revenue Forecast, 2014-2024
4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2014-2024
4.1 Leading National Markets: The US Dominated in 2013
4.2 Leading National Markets: Revenue The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2014-2024
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 Differences Between the US and Europe
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2014-2024
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2013
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.5 France: Pharma Wholesale and Distribution Market, 2013
4.4.5.1 France: Social Security Finance Bill 2014
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2013
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2013
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.8 UK: Pharma Wholesale and Distribution Market, 2013
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.5 Japan: Pharma Wholesale and Distribution Market, 2013
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.6 China: Pharma Wholesale and Distribution Market, 2013
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2013
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.7 Brazil: Pharma Wholesale and Distribution Market, 2013
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2013
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.8 India: Pharma Wholesale and Distribution Market, 2013
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.9 Russia: Pharma Wholesale and Distribution Market, 2013
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.10 Conclusion
5. Leading Pharma Wholesalers and Distributors in 2014: Current and Future Performance
5.1 The Leading Wholesale and Distribution Companies in 2013
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2014-2024
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2008-2013
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2014-2024
5.5 Cardinal Health: The World’s Second Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2008-2013
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2014-2024
5.6 AmerisourceBergen: Third Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2008-2013
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast 2014-2024
5.7 Alliance Boots: The Largest European Wholesaler
5.7.1 Alliance Boots: Historical Performance, 2008-2013
5.7.2 Future Strategies of Alliance Boots: Merger Plan with Walgreens to Become the Largest Provider of Healthcare Services
5.7.3 Alliance Boots: Revenue Forecast, 2014-2024
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2008-2013
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2014-2024
5.9 The PHOENIX Group: Second Biggest Wholesaler in Europe
5.9.1 The PHOENIX Group: Historical Performance, 2008-2013
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisitions
5.9.3 The PHOENIX Group: Revenue Forecast, 2014-2024
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2008-2013
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2014-2024
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2008-2013
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2014-2024
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO., LTD: Historical Performance, 2008-2013
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2014-2024
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2008-2013
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2014-2024
6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2014
6.1.1 The Insatiable Demand for Drugs: A Recession-Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2. The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2014-2024
6.2.1The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country to Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4.0 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2014-2024 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.2.3.4 Serialisation for Wholesalers: Opportunity or a Challenge?
7. Research Interviews
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd. (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market in the UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More Than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
7.2 Interview with Dr Evelyn Walter, Co-Founder and Director of the Institute for Pharmaeconomic Research (IPF), Vienna
7.2.1 On Direct-to-Pharmacy Distribution
7.2.2 On the Effect of Drug Pricing Pressures on the Supply of Pharmaceuticals
7.2.3 On the Role of Pharmaceutical Wholesalers and Distributors in European Healthcare Systems
7.2.4 On the Impact of Counterfeit Drugs
7.2.5 On the Efficacy of the Pharmaceutical Wholesale and Distribution Industry
8. Conclusions from the Research and Analysis
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesaler’s Costs
【レポート販売概要】
■ タイトル:世界の医薬品卸売及び流通市場:地域別分析、主要企業分析■ 英文:PHARMA WHOLESALE AND DISTRIBUTION INDUSTRY AND MARKET: WORLD OUTLOOKS AND FORECASTS 2014-2024
■ 発行日:2014年9月
■ 調査会社:visiongain
■ 商品コード:VISG409042
■ 調査対象地域:グローバル
- ポリスチレン(PS)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world Polystyrene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insig …
- OTT(Over-The-Top)サービスの世界市場:用途別(通信、eサービス、Webコンテンツ、クラウドサービス)、最終用途別(パーソナル、商業)、地域別予測Global Over the top services Market to reach USD 3634.7 billion by 2025. Global Over the top services Market valued approximately USD 912.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 16.6% over the forecast period 2017-2025. Key factors which gives growth to the Over the top services market are the demand for OTT services is poised to rise exponentially in the c …
- 世界のCRBN(化学・生物・放射性物質・核)防衛市場動向2013-2023:市場のSWOT分析This SWOT analysis of CBRN market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global CBRN Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI strictly follows a standardized rese …
- コンクリート流動化剤の世界市場動向および予測(~2020)The market size of concrete superplasticizers (CSP), in terms of value, is projected to reach USD 4.77 Billion by 2020, at a CAGR of 8.2% between 2015 and 2020. Growing demand from the emerging economies, and ecological and cost benefits are key factors driving the growth of the global CSP market. The ready-mix (RMC) segment is projected to be the fastest-growing application of concrete superplast …
- ホームフレグランスの世界市場:製品別(ディフューザー、スプレー、香料入りのろうそく、その他)、流通チャネル別(スーパーマーケット/ハイパーマーケット、オンラインストア、コンビニエンスストアなど)Home fragrances are home care products that emit aroma that helps mask unpleasant odor. Home fragrance products differ as per the functionalities. Some of the home fragrance products help relieve stress, whereas some of them facilitate homely ambience through their scented aroma... Some of the most common home fragrances preferred by the consumers include fantasy, floral, fresh & clean fruity, and …
- 世界における頭蓋顎顔面固定(CMF)デバイスの製品パイプライン動向2015Cranio Maxillofacial Fixation (CMF) - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Cranio Maxillofacial Fixation (CMF) - Pipeline Review, 2015" provides an overview of Cranio Maxillofacial Fixation currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of developme …
- アメリカの試験準備サービス市場2016-2020About the Test Preparation Market The benchmarking in the education system is highly useful in measuring the performance of students, teachers, and schools. The test preparation industry has emerged alongside with the extensive standardization of the education sector in the US. This standardization essentially refers to the provision of exam preparation services to students to help them score well …
- 合成繊維の世界市場:ポリエステル類、ポリアミド類、ポリアクリル酸類About Synthetic fibers Synthetic fibers are man-made materials that are formed using chemicals that have superior properties as compared to natural fibers. These fibers are created through polymerization of various chemical substances. Synthetic fibers are more durable, easy to dye, stain-resistant and lighter. These fibers are used widely in the Fashion industry for various applications because o …
- 高性能ポリアミドの世界市場展望2017-2026According to Stratistics MRC, the Global High-Performance Polyamides market is accounted for $1.84 billion in 2017 and is expected to reach $3.77 billion by 2026 growing at a CAGR of 8.3% during the forecast period. Some of the key factors such as an increase in demand for high-performance polyamides in the medical industry and growing importance on weight diminution in the automotive sector are d …
- アクセス制御製品の世界市場:カード、リーダー、バイオメトリクス(生体認証)、コントローラ、アクセス制御管理ソフトウェアCurrently, cloud computing is one of the fastest growing segments in the semiconductor and telecommunication industry, with the researchers continually integrating cloud with different technologies; access control being one of them. With the unification of cloud services with the access control systems, the users were able to get rid of the mesh of wires and huge controllers that were used in the …
- 接着剤・複合材料・塗料用エポキシ樹脂の世界市場予測(~2020)The adhesive, composite, and coating epoxy market size is estimated to reach USD 9.96 Billion by 2020, signifying a CAGR of over 5.8% between 2015 and 2020. The emerging middle class population of China, India, and Brazil; changing life style; and improving standard of living of consumers depict the increasing demand for high quality products. These are the important factors responsible for growth …
- Salamander Energy plc:石油・ガスバリューチェーン分析レポート2013Salamander Energy plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Salamander Energy plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Salamander Energy plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- 日本の注射器・注射針市場見通し(~2021)Japan Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "Japan Syringes and Needles Market Outlook to 2021", provides key market data on the Japan Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syringes. The report also p …
- セーフティライトカーテンの世界市場予測(~2025年)“Safety light curtain market to grow at a CAGR of 6.5% from 2019 to 2025” The safety light curtain market is expected to grow from USD 1.1 billion by 2019 to USD 1.6 billion by 2025 at a CAGR of 6.5% from 2019 to 2025. A few key factors driving the growth of this market include the rise in Industry 4.0; the growing use of robotics in the packaging industry; and mandatory safety regulations across …
- 航空宇宙用複合材の世界市場予測:ガラス繊維複合材、炭素繊維複合材、アラミド繊維複合材The global aerospace composites market is projected to reach USD 32.35 Billion by 2021, at a CAGR of 8.95%, from 2016 to 2021. The increasing demand for high strength, light weight and fuel efficient materials and the high worldwide growth in the aerospace industry are the key factors responsible for the growth of the global aerospace composites market. The global aerospace composites market is se …